Mezei ZA - Search Results

1

Factor XIII B subunit polymorphisms and the risk of coronary artery disease.

Mezei ZA, Bereczky Z, Katona É, Gindele R, Balogh E, Fiatal S, Balogh L, Czuriga I, Ádány R, Édes I, Muszbek L. Mezei ZA, et al. Int J Mol Sci. 2015 Jan 6;16(1):1143-59. doi: 10.3390/ijms16011143. Int J Mol Sci. 2015. PMID: 25569091 Free PMC article.

2

Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation.

Koncz Z, Bagoly Z, Haramura G, Mezei ZA, Muszbek L. Koncz Z, et al. Among authors: mezei za. Thromb Res. 2012 Apr;129(4):508-13. doi: 10.1016/j.thromres.2011.06.030. Epub 2011 Jul 20. Thromb Res. 2012. PMID: 21774968

3

Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.

Koncz Z, Bagoly Z, Haramura G, Mezei ZA, Muszbek L. Koncz Z, et al. Among authors: mezei za. Thromb Res. 2012 Sep;130(3):528-34. doi: 10.1016/j.thromres.2012.05.019. Epub 2012 Jun 15. Thromb Res. 2012. PMID: 22704462

4

Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.

Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z. Shemirani AH, et al. Among authors: mezei za. Blood Coagul Fibrinolysis. 2014 Jun;25(4):364-8. doi: 10.1097/MBC.0000000000000055. Blood Coagul Fibrinolysis. 2014. PMID: 24686102

5

Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.

Mezei ZA, Katona É, Kállai J, Bereczky Z, Molnár É, Kovács B, Ajzner É, Bagoly Z, Miklós T, Muszbek L. Mezei ZA, et al. Thromb Res. 2016 Dec;148:101-106. doi: 10.1016/j.thromres.2016.10.025. Epub 2016 Oct 27. Thromb Res. 2016. PMID: 27821352

6

Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.

Mezei ZA, Katona É, Kállai J, Bereczky Z, Somodi L, Molnár É, Kovács B, Miklós T, Ajzner É, Muszbek L. Mezei ZA, et al. Thromb Res. 2017 Oct;158:93-97. doi: 10.1016/j.thromres.2017.08.018. Epub 2017 Aug 26. Thromb Res. 2017. PMID: 28865246

7

Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.

Balogh L, Katona É, Mezei ZA, Kállai J, Gindele R, Édes I, Muszbek L, Papp Z, Bereczky Z. Balogh L, et al. Among authors: mezei za. Mol Cell Biochem. 2018 Nov;448(1-2):199-209. doi: 10.1007/s11010-018-3326-8. Epub 2018 Feb 26. Mol Cell Biochem. 2018. PMID: 29484525 Clinical Trial.

8

Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.

Székely EG, Czuriga-Kovács KR, Bereczky Z, Katona É, Mezei ZA, Nagy A, Tóth NK, Berényi E, Muszbek L, Csiba L, Bagoly Z. Székely EG, et al. Among authors: mezei za. Sci Rep. 2018 May 16;8(1):7662. doi: 10.1038/s41598-018-26025-z. Sci Rep. 2018. PMID: 29769590 Free PMC article.

9

Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.

Bereczky Z, Gindele R, Fiatal S, Speker M, Miklós T, Balogh L, Mezei Z, Szabó Z, Ádány R. Bereczky Z, et al. Front Cardiovasc Med. 2021 Feb 5;7:617711. doi: 10.3389/fcvm.2020.617711. eCollection 2020. Front Cardiovasc Med. 2021. PMID: 33614741 Free PMC article.

10

Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.

Baráth B, Bogáti R, Miklós T, Kállai J, Mezei ZA, Bereczky Z, Muszbek L, Katona É. Baráth B, et al. Among authors: mezei za. Thromb Res. 2021 Jul;203:110-116. doi: 10.1016/j.thromres.2021.05.003. Epub 2021 May 11. Thromb Res. 2021. PMID: 33992873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters